BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260407T091556
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:15849-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260407T091556
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:26371-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260407T091556
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:27986-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260407T091556
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:31069-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210409T120000
DTEND;TZID=America/Vancouver:20210409T133000
DTSTAMP:20260407T091556
CREATED:20210401T000331Z
LAST-MODIFIED:20210401T000331Z
UID:32529-1617969600-1617975000@scienceinvancouver.com
SUMMARY:Panel Discussion Parkinson’s Disease: Research\, Innovations and Impacts
DESCRIPTION:The panel discussion will feature experts who will discuss research\, innovations and impacts/lived experiences of Parkinson’s.\n\n\n\n\n\nAbout this Event\n\n\nREGISTER by 2:00 p.m. (PT) on Thursday\, April 8 \n  \nVIRTUAL EVENT \nZoom Webinar – the link to participate will be emailed to registered guests the morning of April 9 from Eventbrite. \n  \nENQUIRIES \nSobhana Jaya-Madhavan | sjayamad@sfu.ca \n  \nFEATURED PANELISTS \n\n\n\nDr. Anish Kanungo\, BSc (Hon)\, PhD\, MD\, FRCPC (Neurology) \nDr. Kanungo attained his PhD in Molecular Biology from the University of Toronto for his work in decoding the molecular pathways which govern neuronal programmed cell death. He then moved west to attend medical school at the University of Calgary\, after which he completed his Neurology Residency training at the University of Manitoba. This was followed by a Fellowship in Movement Disorders at the University of Manitoba funded by Parkinson Canada. He is a Clinical Assistant Professor in the Department of Medicine\, Division of Neurology at the University of British Columbia\, and one of three Movement Disorder Neurologists practicing at the Fraser Health Movement Disorder Clinic\, which provides multi-disciplinary support to patients with movement disorders\, including Parkinson’s disease. He actively participates in the training of medical students and residents\, and maintains an interest in research aimed at improving the lives of people with movement disorders. \n  \n\n\n\nBob de Wit \nBob de Wit is a mentor\, advisor and investor in start-up and growth-stage technology companies. Bob’s career began in university technology transfer then\, transformed by entrepreneurship\, evolved into angel investing. Along the way\, Bob gained C-level leadership experience with start-ups\, public companies\, and not-for-profit societies. Areas of specialized knowledge include corporate development (M&A strategy and execution)\, corporate finance (raising equity capital) and corporate governance. Bob has served on numerous boards and advisory boards of private and public companies as well as societies and foundations. He holds a BBA (marketing) and MA (economics) from Simon Fraser University\, and lives with his family in British Columbia. As a panelist\, Bob will share about his life with young onset Parkinson’s. \n  \n\n\n\nDr. Alexandra T. Greenhill \nDr. Greenhill is one of Canada’s leading physicians in digital health innovation and the cofounder CEO and Chief Medical Officer of Careteam Technologies\, the digital health platform solving the fragmentation of healthcare that was the recipient of the Canadian Medical Associations’ Joule Innovation Award. \nAfter having implemented health innovation at scale and practiced medicine in Quebec\, Ontario and BC\, she now leads and advises Canada’s most promising technology companies. Dr. Greenhill’s work has received many recognitions\, including Startup Canada’s Woman Entrepreneur of the Year Award\, YWCA Woman of Distinction – Entrepreneurship\, WXN’s Top 100 Most Powerful Women in Canada\, BIV Top 40 under 40 and the Queen Elizabeth II Diamond Jubilee Medal of Service. \n  \n\n\n\nSusan Richards de Wit \nSusan has over 25 years as a management consultant specializing in strategic partnerships\, public relations\, corporate communications and digital strategy. Susan has led projects in everything from start-ups to growth-stage companies\, universities\, and healthcare providers. As a senior leader\, Susan helps to drive change using strategic\, creative\, and fully integrated approaches to marketing communications\, media relations\, and all things digital. Susan helps companies communicate in ways that bring results in disruptive business environments. As a panelist\, Susan will speak about being a care partner and the importance of cross-sector collaboration to fill the gaps in Parkinson’s research and innovation\, early intervention and treatment. Susan graduated from Simon Fraser University. \n  \n\n\n\nDr. Debashis Chanda \nProf. Debashis Chanda is an Associate Professor\, jointly appointed with NanoScience Technology Center\, Dept. of Physics and College of Optics and Photonics (CREOL)\, University of Central Florida (UCF). Dr. Chanda received his PhD from University of Toronto. His PhD work was recognized in the form of several awards\, including the prestigious National Sciences and Engineering Research Council (NSERC) fellowship. Dr. Chanda completed his post-doctoral research with Prof. John A. Rogers at Beckman Institute\, University of Illinois at Urbana-Champaign. Quite a few of these research works were extensively covered by National Science Foundation news\, BBC\, Daily Mail\, NBC\, Fox\, Science Radio and other national/international media outlets. His research has appeared on American Scientist magazine as focused article where it was outlined how companies like Intel\, Toshiba etc.\, are trying to adopt some of the printing techniques which were developed in his group. Dr. Chanda is a recipient of the 2012 DOE Energy Frontier Research Center (EFRC) Solar Energy Future Direction Innovation Proposal Award\, 2013 NSF Summer Institute Fellowship and International Displaying Future Award-2016 by Merck Germany\, UCF Reach of the Stars Award (2018). Dr. Chanda’s research has been supported by NSF\, DARPA\, Florida Space Institute/NASA\, State of Florida\, Northrop Grumman\, Lockheed Martin etc. Apart from that Dr. Chanda is founder of couple of start-ups out of his research in California. \n  \n\n\n\nDr. Frank Lee \nAssociate Professor in the Faculty of Health Sciences at Simon Fraser University \nDr. Lee received his PhD from the University of Toronto in 2002\, where he characterized an interaction between the dopamine transporter and a-synuclein\, a protein implicated in the pathogenesis of Parkinson’s disease. In addition\, his interest in the molecular pathophysiology of schizophrenia led to studies that characterized a direct interaction between the dopamine D1 receptor and the glutamate NMDA receptor. Dr. Lee subsequently pursued a post-doctoral fellowship at Children’s Hospital Boston/Harvard Medical School contributing to studies that demonstrated the role of dopamine in a-synuclein mediated neurotoxicity and examining the molecular components of APP processing. In 2004\, he returned to Toronto to continue his studies investigating the molecular neurobiology of the dopamine system at the Centre for Addiction and Mental Health. Here he led a study examining the cross-talk between the dopamine D2 receptor and the dopamine transporter. \n  \nMODERATOR \n\n\n\nSobhana Jaya-Madhavan \nAssociate Vice President – External Relations at Simon Fraser University \nPrior to joining SFU\, Sobhana worked with BC Government for nearly two decades and at NewGen KnowledgeWorks (India) as Head HR and Associate Vice President. In 2017\, Sobhana joined Simon Fraser University (SFU) as Associate Vice President\, External Relations and engages with all levels of government\, internal/external partners and diverse communities to strengthen relationships and work on shared goals. In 2019\, Sobhana was awarded the Woman of the Decade Award (in Education) by the Women Economic Forum. Sobhana volunteers extensively\, sits on several boards and is passionate about peace\, disruptive technologies and innovation\, cross-cultural dialogue and travel.
URL:https://scienceinvancouver.com/event/panel-discussion-parkinsons-disease-research-innovations-and-impacts-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210412T090000
DTEND;TZID=America/Vancouver:20210412T110000
DTSTAMP:20260407T091556
CREATED:20210304T224252Z
LAST-MODIFIED:20210304T224252Z
UID:15314-1618218000-1618225200@scienceinvancouver.com
SUMMARY:Sex Cells!
DESCRIPTION:It is imperative to consider sex and gender when conducting inclusive research\, building unbiased technology and facilitating equitable healthcare. Research that implements sex- and gender-based analysis plus (SGBA+) has found important differences in many areas that pertain to neuroscience\, including disease risk and effective treatments. Implementation of SGBA+ into your research is often required by funding agencies and will also lead to important discoveries and pathways for precision medicine. \nJoin the Djavad Mowafaghian Centre for Brain Health\, the UBC Women’s Health Research Cluster and the Graduate Program in Neuroscience for this free workshop on how to implement SGBA+ into your own research. It is intended for both faculty and trainees and will be led by Dr. Liisa Galea and Krystle van Hoof (bios below). This workshop includes talks by Dr. Galea and van Hoof\, as well as breakout rooms which will provide the opportunity for small group discussions\, where participants can talk about their own experiences of implementing SGBA+ and share questions and ideas about integrating this into their future research. \nAGENDA\n9:00-9:05 – Welcome \n9:05-9:25 – Krystle van Hoof: What is Sex and Gender Based Analysis and Why is it Important? \n9:25-9:30 – Q&A with Krystle and Liisa Galea \n9:30-9:50 – Liisa Galea: Studying Sex and Sex-Specific Factors in Brain Health and Disease \n9:50-10:10 – Q&A with Krystle and Liisa Galea \n10:15-11:00 – Breakout Rooms: SGBA considerations in research \nSPEAKERS\n\n\n\n\nTalk Title: What is Sex and Gender Based Analysis and Why is it Important? \nThis talk will provide an overview of what SGBA+ is and why it is important and will review examples of studies that have implemented SGBA+. It will also discuss how SGBA+ can enhance your research and increase your ability to get published and funded. \nBio: Krystle van Hoof is the Managing Director and CEO of Healthy Brains\, Healthy Lives\, a large-scale neuroinformatics initiative at McGill University. She has previously held a variety of leadership positions within the Canadian not-profit sector as well as the Canadian federal government and the United Nations. Krystle has worked in private sector marketing as well as non-profit communications and has led communications departments for two national Canadian associations—work that has been recognized with national awards. Directly prior to her current post\, Krystle held the position of Assistant Director with the Institute of Gender and Health\, one of 13 institutes that make up the Canadian Institutes of Health Research. In this role\, she worked to convince health researchers and trainees to integrate sex- and gender-based analysis plus (SGBA+) into their work (with some success and many heated discussions!) Krystle holds an MA in Communication for Development from Malmö University\, a BA in Cultural Studies from York University and a Professional Certificate in Knowledge Translation from the University of Toronto. \n \n\n\n\nTalk Title: Studying Sex and Sex-Specific Factors in Brain Health and Disease \nThis talk will feature the many types of sex differences that can be examined. We will talk about studying sex differences without sexism\, and the need to  “dig deeper” into SBGA. The talk will also highlight that SGBA is only the first step in towards precision medicine for women and men’s health \nBio: Dr. Liisa Galea is a Professor in the Department of Psychology\, and a member of the Centre for Brain Health\, Director of the Graduate Program in Neuroscience\, Lead of the Women’s Health Research Cluster at UBC\, and a Scientific Advisor at Women’s Health Research Institute at the University of British Columbia. Her research investigates how sex hormones influence brain health and disease in both females and males. The main goal of her research is to improve brain health for women and men by examining the influence of sex and sex hormones on normal and diseased brain states such as depression and Alzheimer’s disease.
URL:https://scienceinvancouver.com/event/sex-cells/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/sex-cells.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210412T090000
DTEND;TZID=America/Vancouver:20210412T110000
DTSTAMP:20260407T091556
CREATED:20210304T224252Z
LAST-MODIFIED:20210304T224252Z
UID:26353-1618218000-1618225200@scienceinvancouver.com
SUMMARY:Sex Cells!
DESCRIPTION:It is imperative to consider sex and gender when conducting inclusive research\, building unbiased technology and facilitating equitable healthcare. Research that implements sex- and gender-based analysis plus (SGBA+) has found important differences in many areas that pertain to neuroscience\, including disease risk and effective treatments. Implementation of SGBA+ into your research is often required by funding agencies and will also lead to important discoveries and pathways for precision medicine. \nJoin the Djavad Mowafaghian Centre for Brain Health\, the UBC Women’s Health Research Cluster and the Graduate Program in Neuroscience for this free workshop on how to implement SGBA+ into your own research. It is intended for both faculty and trainees and will be led by Dr. Liisa Galea and Krystle van Hoof (bios below). This workshop includes talks by Dr. Galea and van Hoof\, as well as breakout rooms which will provide the opportunity for small group discussions\, where participants can talk about their own experiences of implementing SGBA+ and share questions and ideas about integrating this into their future research. \nAGENDA\n9:00-9:05 – Welcome \n9:05-9:25 – Krystle van Hoof: What is Sex and Gender Based Analysis and Why is it Important? \n9:25-9:30 – Q&A with Krystle and Liisa Galea \n9:30-9:50 – Liisa Galea: Studying Sex and Sex-Specific Factors in Brain Health and Disease \n9:50-10:10 – Q&A with Krystle and Liisa Galea \n10:15-11:00 – Breakout Rooms: SGBA considerations in research \nSPEAKERS\n\n\n\n\nTalk Title: What is Sex and Gender Based Analysis and Why is it Important? \nThis talk will provide an overview of what SGBA+ is and why it is important and will review examples of studies that have implemented SGBA+. It will also discuss how SGBA+ can enhance your research and increase your ability to get published and funded. \nBio: Krystle van Hoof is the Managing Director and CEO of Healthy Brains\, Healthy Lives\, a large-scale neuroinformatics initiative at McGill University. She has previously held a variety of leadership positions within the Canadian not-profit sector as well as the Canadian federal government and the United Nations. Krystle has worked in private sector marketing as well as non-profit communications and has led communications departments for two national Canadian associations—work that has been recognized with national awards. Directly prior to her current post\, Krystle held the position of Assistant Director with the Institute of Gender and Health\, one of 13 institutes that make up the Canadian Institutes of Health Research. In this role\, she worked to convince health researchers and trainees to integrate sex- and gender-based analysis plus (SGBA+) into their work (with some success and many heated discussions!) Krystle holds an MA in Communication for Development from Malmö University\, a BA in Cultural Studies from York University and a Professional Certificate in Knowledge Translation from the University of Toronto. \n \n\n\n\nTalk Title: Studying Sex and Sex-Specific Factors in Brain Health and Disease \nThis talk will feature the many types of sex differences that can be examined. We will talk about studying sex differences without sexism\, and the need to  “dig deeper” into SBGA. The talk will also highlight that SGBA is only the first step in towards precision medicine for women and men’s health \nBio: Dr. Liisa Galea is a Professor in the Department of Psychology\, and a member of the Centre for Brain Health\, Director of the Graduate Program in Neuroscience\, Lead of the Women’s Health Research Cluster at UBC\, and a Scientific Advisor at Women’s Health Research Institute at the University of British Columbia. Her research investigates how sex hormones influence brain health and disease in both females and males. The main goal of her research is to improve brain health for women and men by examining the influence of sex and sex hormones on normal and diseased brain states such as depression and Alzheimer’s disease.
URL:https://scienceinvancouver.com/event/sex-cells-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/sex-cells.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210412T090000
DTEND;TZID=America/Vancouver:20210412T110000
DTSTAMP:20260407T091556
CREATED:20210304T224252Z
LAST-MODIFIED:20210304T224252Z
UID:27968-1618218000-1618225200@scienceinvancouver.com
SUMMARY:Sex Cells!
DESCRIPTION:It is imperative to consider sex and gender when conducting inclusive research\, building unbiased technology and facilitating equitable healthcare. Research that implements sex- and gender-based analysis plus (SGBA+) has found important differences in many areas that pertain to neuroscience\, including disease risk and effective treatments. Implementation of SGBA+ into your research is often required by funding agencies and will also lead to important discoveries and pathways for precision medicine. \nJoin the Djavad Mowafaghian Centre for Brain Health\, the UBC Women’s Health Research Cluster and the Graduate Program in Neuroscience for this free workshop on how to implement SGBA+ into your own research. It is intended for both faculty and trainees and will be led by Dr. Liisa Galea and Krystle van Hoof (bios below). This workshop includes talks by Dr. Galea and van Hoof\, as well as breakout rooms which will provide the opportunity for small group discussions\, where participants can talk about their own experiences of implementing SGBA+ and share questions and ideas about integrating this into their future research. \nAGENDA\n9:00-9:05 – Welcome \n9:05-9:25 – Krystle van Hoof: What is Sex and Gender Based Analysis and Why is it Important? \n9:25-9:30 – Q&A with Krystle and Liisa Galea \n9:30-9:50 – Liisa Galea: Studying Sex and Sex-Specific Factors in Brain Health and Disease \n9:50-10:10 – Q&A with Krystle and Liisa Galea \n10:15-11:00 – Breakout Rooms: SGBA considerations in research \nSPEAKERS\n\n\n\n\nTalk Title: What is Sex and Gender Based Analysis and Why is it Important? \nThis talk will provide an overview of what SGBA+ is and why it is important and will review examples of studies that have implemented SGBA+. It will also discuss how SGBA+ can enhance your research and increase your ability to get published and funded. \nBio: Krystle van Hoof is the Managing Director and CEO of Healthy Brains\, Healthy Lives\, a large-scale neuroinformatics initiative at McGill University. She has previously held a variety of leadership positions within the Canadian not-profit sector as well as the Canadian federal government and the United Nations. Krystle has worked in private sector marketing as well as non-profit communications and has led communications departments for two national Canadian associations—work that has been recognized with national awards. Directly prior to her current post\, Krystle held the position of Assistant Director with the Institute of Gender and Health\, one of 13 institutes that make up the Canadian Institutes of Health Research. In this role\, she worked to convince health researchers and trainees to integrate sex- and gender-based analysis plus (SGBA+) into their work (with some success and many heated discussions!) Krystle holds an MA in Communication for Development from Malmö University\, a BA in Cultural Studies from York University and a Professional Certificate in Knowledge Translation from the University of Toronto. \n \n\n\n\nTalk Title: Studying Sex and Sex-Specific Factors in Brain Health and Disease \nThis talk will feature the many types of sex differences that can be examined. We will talk about studying sex differences without sexism\, and the need to  “dig deeper” into SBGA. The talk will also highlight that SGBA is only the first step in towards precision medicine for women and men’s health \nBio: Dr. Liisa Galea is a Professor in the Department of Psychology\, and a member of the Centre for Brain Health\, Director of the Graduate Program in Neuroscience\, Lead of the Women’s Health Research Cluster at UBC\, and a Scientific Advisor at Women’s Health Research Institute at the University of British Columbia. Her research investigates how sex hormones influence brain health and disease in both females and males. The main goal of her research is to improve brain health for women and men by examining the influence of sex and sex hormones on normal and diseased brain states such as depression and Alzheimer’s disease.
URL:https://scienceinvancouver.com/event/sex-cells-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/sex-cells.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210412T090000
DTEND;TZID=America/Vancouver:20210412T110000
DTSTAMP:20260407T091556
CREATED:20210304T224252Z
LAST-MODIFIED:20210304T224252Z
UID:31051-1618218000-1618225200@scienceinvancouver.com
SUMMARY:Sex Cells!
DESCRIPTION:It is imperative to consider sex and gender when conducting inclusive research\, building unbiased technology and facilitating equitable healthcare. Research that implements sex- and gender-based analysis plus (SGBA+) has found important differences in many areas that pertain to neuroscience\, including disease risk and effective treatments. Implementation of SGBA+ into your research is often required by funding agencies and will also lead to important discoveries and pathways for precision medicine. \nJoin the Djavad Mowafaghian Centre for Brain Health\, the UBC Women’s Health Research Cluster and the Graduate Program in Neuroscience for this free workshop on how to implement SGBA+ into your own research. It is intended for both faculty and trainees and will be led by Dr. Liisa Galea and Krystle van Hoof (bios below). This workshop includes talks by Dr. Galea and van Hoof\, as well as breakout rooms which will provide the opportunity for small group discussions\, where participants can talk about their own experiences of implementing SGBA+ and share questions and ideas about integrating this into their future research. \nAGENDA\n9:00-9:05 – Welcome \n9:05-9:25 – Krystle van Hoof: What is Sex and Gender Based Analysis and Why is it Important? \n9:25-9:30 – Q&A with Krystle and Liisa Galea \n9:30-9:50 – Liisa Galea: Studying Sex and Sex-Specific Factors in Brain Health and Disease \n9:50-10:10 – Q&A with Krystle and Liisa Galea \n10:15-11:00 – Breakout Rooms: SGBA considerations in research \nSPEAKERS\n\n\n\n\nTalk Title: What is Sex and Gender Based Analysis and Why is it Important? \nThis talk will provide an overview of what SGBA+ is and why it is important and will review examples of studies that have implemented SGBA+. It will also discuss how SGBA+ can enhance your research and increase your ability to get published and funded. \nBio: Krystle van Hoof is the Managing Director and CEO of Healthy Brains\, Healthy Lives\, a large-scale neuroinformatics initiative at McGill University. She has previously held a variety of leadership positions within the Canadian not-profit sector as well as the Canadian federal government and the United Nations. Krystle has worked in private sector marketing as well as non-profit communications and has led communications departments for two national Canadian associations—work that has been recognized with national awards. Directly prior to her current post\, Krystle held the position of Assistant Director with the Institute of Gender and Health\, one of 13 institutes that make up the Canadian Institutes of Health Research. In this role\, she worked to convince health researchers and trainees to integrate sex- and gender-based analysis plus (SGBA+) into their work (with some success and many heated discussions!) Krystle holds an MA in Communication for Development from Malmö University\, a BA in Cultural Studies from York University and a Professional Certificate in Knowledge Translation from the University of Toronto. \n \n\n\n\nTalk Title: Studying Sex and Sex-Specific Factors in Brain Health and Disease \nThis talk will feature the many types of sex differences that can be examined. We will talk about studying sex differences without sexism\, and the need to  “dig deeper” into SBGA. The talk will also highlight that SGBA is only the first step in towards precision medicine for women and men’s health \nBio: Dr. Liisa Galea is a Professor in the Department of Psychology\, and a member of the Centre for Brain Health\, Director of the Graduate Program in Neuroscience\, Lead of the Women’s Health Research Cluster at UBC\, and a Scientific Advisor at Women’s Health Research Institute at the University of British Columbia. Her research investigates how sex hormones influence brain health and disease in both females and males. The main goal of her research is to improve brain health for women and men by examining the influence of sex and sex hormones on normal and diseased brain states such as depression and Alzheimer’s disease.
URL:https://scienceinvancouver.com/event/sex-cells-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/sex-cells.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210412T090000
DTEND;TZID=America/Vancouver:20210412T110000
DTSTAMP:20260407T091556
CREATED:20210304T224252Z
LAST-MODIFIED:20210304T224252Z
UID:32511-1618218000-1618225200@scienceinvancouver.com
SUMMARY:Sex Cells!
DESCRIPTION:It is imperative to consider sex and gender when conducting inclusive research\, building unbiased technology and facilitating equitable healthcare. Research that implements sex- and gender-based analysis plus (SGBA+) has found important differences in many areas that pertain to neuroscience\, including disease risk and effective treatments. Implementation of SGBA+ into your research is often required by funding agencies and will also lead to important discoveries and pathways for precision medicine. \nJoin the Djavad Mowafaghian Centre for Brain Health\, the UBC Women’s Health Research Cluster and the Graduate Program in Neuroscience for this free workshop on how to implement SGBA+ into your own research. It is intended for both faculty and trainees and will be led by Dr. Liisa Galea and Krystle van Hoof (bios below). This workshop includes talks by Dr. Galea and van Hoof\, as well as breakout rooms which will provide the opportunity for small group discussions\, where participants can talk about their own experiences of implementing SGBA+ and share questions and ideas about integrating this into their future research. \nAGENDA\n9:00-9:05 – Welcome \n9:05-9:25 – Krystle van Hoof: What is Sex and Gender Based Analysis and Why is it Important? \n9:25-9:30 – Q&A with Krystle and Liisa Galea \n9:30-9:50 – Liisa Galea: Studying Sex and Sex-Specific Factors in Brain Health and Disease \n9:50-10:10 – Q&A with Krystle and Liisa Galea \n10:15-11:00 – Breakout Rooms: SGBA considerations in research \nSPEAKERS\n\n\n\n\nTalk Title: What is Sex and Gender Based Analysis and Why is it Important? \nThis talk will provide an overview of what SGBA+ is and why it is important and will review examples of studies that have implemented SGBA+. It will also discuss how SGBA+ can enhance your research and increase your ability to get published and funded. \nBio: Krystle van Hoof is the Managing Director and CEO of Healthy Brains\, Healthy Lives\, a large-scale neuroinformatics initiative at McGill University. She has previously held a variety of leadership positions within the Canadian not-profit sector as well as the Canadian federal government and the United Nations. Krystle has worked in private sector marketing as well as non-profit communications and has led communications departments for two national Canadian associations—work that has been recognized with national awards. Directly prior to her current post\, Krystle held the position of Assistant Director with the Institute of Gender and Health\, one of 13 institutes that make up the Canadian Institutes of Health Research. In this role\, she worked to convince health researchers and trainees to integrate sex- and gender-based analysis plus (SGBA+) into their work (with some success and many heated discussions!) Krystle holds an MA in Communication for Development from Malmö University\, a BA in Cultural Studies from York University and a Professional Certificate in Knowledge Translation from the University of Toronto. \n \n\n\n\nTalk Title: Studying Sex and Sex-Specific Factors in Brain Health and Disease \nThis talk will feature the many types of sex differences that can be examined. We will talk about studying sex differences without sexism\, and the need to  “dig deeper” into SBGA. The talk will also highlight that SGBA is only the first step in towards precision medicine for women and men’s health \nBio: Dr. Liisa Galea is a Professor in the Department of Psychology\, and a member of the Centre for Brain Health\, Director of the Graduate Program in Neuroscience\, Lead of the Women’s Health Research Cluster at UBC\, and a Scientific Advisor at Women’s Health Research Institute at the University of British Columbia. Her research investigates how sex hormones influence brain health and disease in both females and males. The main goal of her research is to improve brain health for women and men by examining the influence of sex and sex hormones on normal and diseased brain states such as depression and Alzheimer’s disease.
URL:https://scienceinvancouver.com/event/sex-cells-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/sex-cells.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210413T130000
DTEND;TZID=America/Vancouver:20210413T140000
DTSTAMP:20260407T091556
CREATED:20210325T170713Z
LAST-MODIFIED:20210412T233906Z
UID:15784-1618318800-1618322400@scienceinvancouver.com
SUMMARY:Diabetes Research: From Hormones to Social Influences - Meet the Researchers #3
DESCRIPTION:BCDRN Meet the Researchers #3 \nDiabetes Research: From hormones to social influences. \nApril 13 at 1 pm (PST) \nDr Annalijn Conklin\, Assistant Professor\, UBC Faculty of Pharmaceutical Sciences \nDr Jim Johnson\, Professor\, Department of Cellular and Physiological Sciences\, Faculty of Medicine\, UBC \nRegistration link \nTo commemorate the 100th anniversary of the discovery of insulin the BC Diabetes Research Network is delighted to introduce our faculty. This series of spotlight sessions will highlight two faculty members and the research they do. Meet BCDRN faculty members and learn about their career\, their research\, ask questions and have a conversation with our faculty about the future of diabetes research. Join us throughout 2021 for this interactive and engaging virtual Zoom series. Please join us for this opportunity to engage with diabetes researchers from across British Columbia.
URL:https://scienceinvancouver.com/event/diabetes-research-from-hormones-to-social-influences-meet-the-researchers-3/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210413T130000
DTEND;TZID=America/Vancouver:20210413T140000
DTSTAMP:20260407T091556
CREATED:20210325T170713Z
LAST-MODIFIED:20210325T170713Z
UID:26367-1618318800-1618322400@scienceinvancouver.com
SUMMARY:Diabetes Research: From Hormones to Social Influences - Meet the Researchers #3
DESCRIPTION:BCDRN Meet the Researchers #3 \nDiabetes Research: From hormones to social influences. \nApril 13 at 1 pm (PST) \nDr Annalijn Conklin\, Assistant Professor\, UBC Faculty of Pharmaceutical Sciences \nDr Jim Johnson\, Professor\, Department of Cellular and Physiological Sciences\, Faculty of Medicine\, UBC \nRegistration link \nTo commemorate the 100th anniversary of the discovery of insulin the BC Diabetes Research Network is delighted to introduce our faculty. This series of spotlight sessions will highlight two faculty members and the research they do. Meet BCDRN faculty members and learn about their career\, their research\, ask questions and have a conversation with our faculty about the future of diabetes research. Join us throughout 2021 for this interactive and engaging virtual Zoom series. Please join us for this opportunity to engage with diabetes researchers from across British Columbia.
URL:https://scienceinvancouver.com/event/diabetes-research-from-hormones-to-social-influences-meet-the-researchers-3-2/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210413T130000
DTEND;TZID=America/Vancouver:20210413T140000
DTSTAMP:20260407T091556
CREATED:20210325T170713Z
LAST-MODIFIED:20210325T170713Z
UID:27982-1618318800-1618322400@scienceinvancouver.com
SUMMARY:Diabetes Research: From Hormones to Social Influences - Meet the Researchers #3
DESCRIPTION:BCDRN Meet the Researchers #3 \nDiabetes Research: From hormones to social influences. \nApril 13 at 1 pm (PST) \nDr Annalijn Conklin\, Assistant Professor\, UBC Faculty of Pharmaceutical Sciences \nDr Jim Johnson\, Professor\, Department of Cellular and Physiological Sciences\, Faculty of Medicine\, UBC \nRegistration link \nTo commemorate the 100th anniversary of the discovery of insulin the BC Diabetes Research Network is delighted to introduce our faculty. This series of spotlight sessions will highlight two faculty members and the research they do. Meet BCDRN faculty members and learn about their career\, their research\, ask questions and have a conversation with our faculty about the future of diabetes research. Join us throughout 2021 for this interactive and engaging virtual Zoom series. Please join us for this opportunity to engage with diabetes researchers from across British Columbia.
URL:https://scienceinvancouver.com/event/diabetes-research-from-hormones-to-social-influences-meet-the-researchers-3-3/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210413T130000
DTEND;TZID=America/Vancouver:20210413T140000
DTSTAMP:20260407T091556
CREATED:20210325T170713Z
LAST-MODIFIED:20210325T170713Z
UID:31065-1618318800-1618322400@scienceinvancouver.com
SUMMARY:Diabetes Research: From Hormones to Social Influences - Meet the Researchers #3
DESCRIPTION:BCDRN Meet the Researchers #3 \nDiabetes Research: From hormones to social influences. \nApril 13 at 1 pm (PST) \nDr Annalijn Conklin\, Assistant Professor\, UBC Faculty of Pharmaceutical Sciences \nDr Jim Johnson\, Professor\, Department of Cellular and Physiological Sciences\, Faculty of Medicine\, UBC \nRegistration link \nTo commemorate the 100th anniversary of the discovery of insulin the BC Diabetes Research Network is delighted to introduce our faculty. This series of spotlight sessions will highlight two faculty members and the research they do. Meet BCDRN faculty members and learn about their career\, their research\, ask questions and have a conversation with our faculty about the future of diabetes research. Join us throughout 2021 for this interactive and engaging virtual Zoom series. Please join us for this opportunity to engage with diabetes researchers from across British Columbia.
URL:https://scienceinvancouver.com/event/diabetes-research-from-hormones-to-social-influences-meet-the-researchers-3-4/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210413T130000
DTEND;TZID=America/Vancouver:20210413T140000
DTSTAMP:20260407T091556
CREATED:20210325T170713Z
LAST-MODIFIED:20210325T170713Z
UID:32525-1618318800-1618322400@scienceinvancouver.com
SUMMARY:Diabetes Research: From Hormones to Social Influences - Meet the Researchers #3
DESCRIPTION:BCDRN Meet the Researchers #3 \nDiabetes Research: From hormones to social influences. \nApril 13 at 1 pm (PST) \nDr Annalijn Conklin\, Assistant Professor\, UBC Faculty of Pharmaceutical Sciences \nDr Jim Johnson\, Professor\, Department of Cellular and Physiological Sciences\, Faculty of Medicine\, UBC \nRegistration link \nTo commemorate the 100th anniversary of the discovery of insulin the BC Diabetes Research Network is delighted to introduce our faculty. This series of spotlight sessions will highlight two faculty members and the research they do. Meet BCDRN faculty members and learn about their career\, their research\, ask questions and have a conversation with our faculty about the future of diabetes research. Join us throughout 2021 for this interactive and engaging virtual Zoom series. Please join us for this opportunity to engage with diabetes researchers from across British Columbia.
URL:https://scienceinvancouver.com/event/diabetes-research-from-hormones-to-social-influences-meet-the-researchers-3-5/
LOCATION:Online
ORGANIZER;CN="BC Diabetes Research Network":MAILTO:meg.hughes@ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T100000
DTEND;TZID=America/Vancouver:20210414T110000
DTSTAMP:20260407T091556
CREATED:20210408T212757Z
LAST-MODIFIED:20210408T212757Z
UID:15960-1618394400-1618398000@scienceinvancouver.com
SUMMARY:Parkinson's Disease Awareness Day 2021
DESCRIPTION:April is Parkinson’s Awareness Month. Join us online for a free educational webinar. \nEnjoy talks from our UBC Movement Disorders Clinic’s neurologists Drs. Jonathan Squires\, Melissa Mackenzie\, and Tara Rastin\, a musical exercise break\, raffle draw\, and good company. \nClick here to register!
URL:https://scienceinvancouver.com/event/parkinsons-disease-awareness-day-2021/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T100000
DTEND;TZID=America/Vancouver:20210414T110000
DTSTAMP:20260407T091556
CREATED:20210408T212757Z
LAST-MODIFIED:20210408T212757Z
UID:26376-1618394400-1618398000@scienceinvancouver.com
SUMMARY:Parkinson's Disease Awareness Day 2021
DESCRIPTION:April is Parkinson’s Awareness Month. Join us online for a free educational webinar. \nEnjoy talks from our UBC Movement Disorders Clinic’s neurologists Drs. Jonathan Squires\, Melissa Mackenzie\, and Tara Rastin\, a musical exercise break\, raffle draw\, and good company. \nClick here to register!
URL:https://scienceinvancouver.com/event/parkinsons-disease-awareness-day-2021-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T100000
DTEND;TZID=America/Vancouver:20210414T110000
DTSTAMP:20260407T091556
CREATED:20210408T212757Z
LAST-MODIFIED:20210408T212757Z
UID:27991-1618394400-1618398000@scienceinvancouver.com
SUMMARY:Parkinson's Disease Awareness Day 2021
DESCRIPTION:April is Parkinson’s Awareness Month. Join us online for a free educational webinar. \nEnjoy talks from our UBC Movement Disorders Clinic’s neurologists Drs. Jonathan Squires\, Melissa Mackenzie\, and Tara Rastin\, a musical exercise break\, raffle draw\, and good company. \nClick here to register!
URL:https://scienceinvancouver.com/event/parkinsons-disease-awareness-day-2021-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T100000
DTEND;TZID=America/Vancouver:20210414T110000
DTSTAMP:20260407T091556
CREATED:20210408T212757Z
LAST-MODIFIED:20210408T212757Z
UID:31074-1618394400-1618398000@scienceinvancouver.com
SUMMARY:Parkinson's Disease Awareness Day 2021
DESCRIPTION:April is Parkinson’s Awareness Month. Join us online for a free educational webinar. \nEnjoy talks from our UBC Movement Disorders Clinic’s neurologists Drs. Jonathan Squires\, Melissa Mackenzie\, and Tara Rastin\, a musical exercise break\, raffle draw\, and good company. \nClick here to register!
URL:https://scienceinvancouver.com/event/parkinsons-disease-awareness-day-2021-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T100000
DTEND;TZID=America/Vancouver:20210414T110000
DTSTAMP:20260407T091556
CREATED:20210408T212757Z
LAST-MODIFIED:20210408T212757Z
UID:32534-1618394400-1618398000@scienceinvancouver.com
SUMMARY:Parkinson's Disease Awareness Day 2021
DESCRIPTION:April is Parkinson’s Awareness Month. Join us online for a free educational webinar. \nEnjoy talks from our UBC Movement Disorders Clinic’s neurologists Drs. Jonathan Squires\, Melissa Mackenzie\, and Tara Rastin\, a musical exercise break\, raffle draw\, and good company. \nClick here to register!
URL:https://scienceinvancouver.com/event/parkinsons-disease-awareness-day-2021-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T140000
DTEND;TZID=America/Vancouver:20210414T150000
DTSTAMP:20260407T091556
CREATED:20210409T222327Z
LAST-MODIFIED:20210409T222444Z
UID:15980-1618408800-1618412400@scienceinvancouver.com
SUMMARY:Science Made Casual with Dr. Florian Kuchenbauer
DESCRIPTION:Dr. Florian Kuchenbauer pursued his M.D. and Oncology residency in Germany; he then obtained a Ph.D. at the Terry Fox Laboratory. He now founded the Kuba lab with Dr. Arefeh Rouhi; their research focuses on translational leukemia\, understanding the pathophysiology of acute myeloid leukemia and multiple myeloma. With mastery of both clinical and laboratory perspectives\, Dr. Kuchenbauer is able to conduct state-of-the-art research to improve leukemia patient outcomes. \nLearn more about his life as a PI\, Clinician\, Scientist\, Father\, Partner\, and Mentor. \nJoin us with a beer\, cup of coffee\, or tea for this episode of Science Made Casual.
URL:https://scienceinvancouver.com/event/science-made-casual-with-dr-florian-kuchenbauer/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T140000
DTEND;TZID=America/Vancouver:20210414T150000
DTSTAMP:20260407T091556
CREATED:20210409T222327Z
LAST-MODIFIED:20210409T222327Z
UID:26377-1618408800-1618412400@scienceinvancouver.com
SUMMARY:Science Made Casual with Dr. Florian Kuchenbauer
DESCRIPTION:Dr. Florian Kuchenbauer pursued his M.D. and Oncology residency in Germany; he then obtained a Ph.D. at the Terry Fox Laboratory. He now founded the Kuba lab with Dr. Arefeh Rouhi; their research focuses on translational leukemia\, understanding the pathophysiology of acute myeloid leukemia and multiple myeloma. With mastery of both clinical and laboratory perspectives\, Dr. Kuchenbauer is able to conduct state-of-the-art research to improve leukemia patient outcomes. \nLearn more about his life as a PI\, Clinician\, Scientist\, Father\, Partner\, and Mentor. \nJoin us with a beer\, cup of coffee\, or tea for this episode of Science Made Casual.
URL:https://scienceinvancouver.com/event/science-made-casual-with-dr-florian-kuchenbauer-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T140000
DTEND;TZID=America/Vancouver:20210414T150000
DTSTAMP:20260407T091556
CREATED:20210409T222327Z
LAST-MODIFIED:20210409T222327Z
UID:27992-1618408800-1618412400@scienceinvancouver.com
SUMMARY:Science Made Casual with Dr. Florian Kuchenbauer
DESCRIPTION:Dr. Florian Kuchenbauer pursued his M.D. and Oncology residency in Germany; he then obtained a Ph.D. at the Terry Fox Laboratory. He now founded the Kuba lab with Dr. Arefeh Rouhi; their research focuses on translational leukemia\, understanding the pathophysiology of acute myeloid leukemia and multiple myeloma. With mastery of both clinical and laboratory perspectives\, Dr. Kuchenbauer is able to conduct state-of-the-art research to improve leukemia patient outcomes. \nLearn more about his life as a PI\, Clinician\, Scientist\, Father\, Partner\, and Mentor. \nJoin us with a beer\, cup of coffee\, or tea for this episode of Science Made Casual.
URL:https://scienceinvancouver.com/event/science-made-casual-with-dr-florian-kuchenbauer-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T140000
DTEND;TZID=America/Vancouver:20210414T150000
DTSTAMP:20260407T091556
CREATED:20210409T222327Z
LAST-MODIFIED:20210409T222327Z
UID:31075-1618408800-1618412400@scienceinvancouver.com
SUMMARY:Science Made Casual with Dr. Florian Kuchenbauer
DESCRIPTION:Dr. Florian Kuchenbauer pursued his M.D. and Oncology residency in Germany; he then obtained a Ph.D. at the Terry Fox Laboratory. He now founded the Kuba lab with Dr. Arefeh Rouhi; their research focuses on translational leukemia\, understanding the pathophysiology of acute myeloid leukemia and multiple myeloma. With mastery of both clinical and laboratory perspectives\, Dr. Kuchenbauer is able to conduct state-of-the-art research to improve leukemia patient outcomes. \nLearn more about his life as a PI\, Clinician\, Scientist\, Father\, Partner\, and Mentor. \nJoin us with a beer\, cup of coffee\, or tea for this episode of Science Made Casual.
URL:https://scienceinvancouver.com/event/science-made-casual-with-dr-florian-kuchenbauer-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T140000
DTEND;TZID=America/Vancouver:20210414T150000
DTSTAMP:20260407T091556
CREATED:20210409T222327Z
LAST-MODIFIED:20210409T222327Z
UID:32535-1618408800-1618412400@scienceinvancouver.com
SUMMARY:Science Made Casual with Dr. Florian Kuchenbauer
DESCRIPTION:Dr. Florian Kuchenbauer pursued his M.D. and Oncology residency in Germany; he then obtained a Ph.D. at the Terry Fox Laboratory. He now founded the Kuba lab with Dr. Arefeh Rouhi; their research focuses on translational leukemia\, understanding the pathophysiology of acute myeloid leukemia and multiple myeloma. With mastery of both clinical and laboratory perspectives\, Dr. Kuchenbauer is able to conduct state-of-the-art research to improve leukemia patient outcomes. \nLearn more about his life as a PI\, Clinician\, Scientist\, Father\, Partner\, and Mentor. \nJoin us with a beer\, cup of coffee\, or tea for this episode of Science Made Casual.
URL:https://scienceinvancouver.com/event/science-made-casual-with-dr-florian-kuchenbauer-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T150000
DTEND;TZID=America/Vancouver:20210414T160000
DTSTAMP:20260407T091556
CREATED:20210401T215554Z
LAST-MODIFIED:20210408T161338Z
UID:15857-1618412400-1618416000@scienceinvancouver.com
SUMMARY:SBME & MSL Seminar: Dr. Linda Griffith
DESCRIPTION:Humanizing Drug Development: From Organoids to Organs-on-Chips\nSpeaker: Dr. Linda Griffith – School of Engineering Professor of Teaching Innovation\, Biological Engineering\, and Mechanical Engineering\, Massachusetts Institute of Technology (MIT)\n\n  \nAbstract: “Mice are not little people” – a refrain becoming louder as the strengths and weaknesses of animal models of human disease become more apparent.  At the same time\, three emerging approaches are headed toward integration:  powerful systems biology analysis of cell-cell and intracellular signaling networks in patient-derived samples; 3D tissue engineered models of human organ systems\, often made from stem cells; and micro-fluidic and meso-fluidic devices that enable living systems to be sustained\, perturbed and analyzed for weeks in culture.  This talk will highlight the integration of these rapidly moving fields to understand difficult clinical problems\, with an emphasis on translating academic discoveries into practical use.  Technical challenges in modeling complex diseases with “organs on chips” approaches include the need for relatively large tissue masses and organ-organ cross talk to capture systemic effects\, as well as new ways of thinking about scaling to capture multiple different functionalities from drug clearance to cytokine signaling crosstalk. Examples in gynecology\, metabolic diseases and other chronic inflammatory conditions will be highlighted.\n  \nHosted by: Dr. Peter Zandstra\, Director – Michael Smith Laboratories and the School of Biomedical Engineering\, UBC\n  \nZoom registration link: https://ubc.zoom.us/meeting/register/u5EtdO6prjoiHdUsc6B540q_n7TUcIqTu4cu\n  \nCo-sponsored by: The Michael Smith Laboratories and the UBC School of Biomedical Engineering
URL:https://scienceinvancouver.com/event/sbme-msl-seminar-dr-linda-griffith/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/04/04-14-2021-MSL-Seminar-Series-Linda-Griffith.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T150000
DTEND;TZID=America/Vancouver:20210414T160000
DTSTAMP:20260407T091556
CREATED:20210401T215554Z
LAST-MODIFIED:20210401T215554Z
UID:26372-1618412400-1618416000@scienceinvancouver.com
SUMMARY:SBME & MSL Seminar: Dr. Linda Griffith
DESCRIPTION:Humanizing Drug Development: From Organoids to Organs-on-Chips\nSpeaker: Dr. Linda Griffith – School of Engineering Professor of Teaching Innovation\, Biological Engineering\, and Mechanical Engineering\, Massachusetts Institute of Technology (MIT)\n\n  \nAbstract: “Mice are not little people” – a refrain becoming louder as the strengths and weaknesses of animal models of human disease become more apparent.  At the same time\, three emerging approaches are headed toward integration:  powerful systems biology analysis of cell-cell and intracellular signaling networks in patient-derived samples; 3D tissue engineered models of human organ systems\, often made from stem cells; and micro-fluidic and meso-fluidic devices that enable living systems to be sustained\, perturbed and analyzed for weeks in culture.  This talk will highlight the integration of these rapidly moving fields to understand difficult clinical problems\, with an emphasis on translating academic discoveries into practical use.  Technical challenges in modeling complex diseases with “organs on chips” approaches include the need for relatively large tissue masses and organ-organ cross talk to capture systemic effects\, as well as new ways of thinking about scaling to capture multiple different functionalities from drug clearance to cytokine signaling crosstalk. Examples in gynecology\, metabolic diseases and other chronic inflammatory conditions will be highlighted.\n  \nHosted by: Dr. Peter Zandstra\, Director – Michael Smith Laboratories and the School of Biomedical Engineering\, UBC\n  \nZoom registration link: https://ubc.zoom.us/meeting/register/u5EtdO6prjoiHdUsc6B540q_n7TUcIqTu4cu\n  \nCo-sponsored by: The Michael Smith Laboratories and the UBC School of Biomedical Engineering
URL:https://scienceinvancouver.com/event/sbme-msl-seminar-dr-linda-griffith-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/04/04-14-2021-MSL-Seminar-Series-Linda-Griffith.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T150000
DTEND;TZID=America/Vancouver:20210414T160000
DTSTAMP:20260407T091556
CREATED:20210401T215554Z
LAST-MODIFIED:20210401T215554Z
UID:27987-1618412400-1618416000@scienceinvancouver.com
SUMMARY:SBME & MSL Seminar: Dr. Linda Griffith
DESCRIPTION:Humanizing Drug Development: From Organoids to Organs-on-Chips\nSpeaker: Dr. Linda Griffith – School of Engineering Professor of Teaching Innovation\, Biological Engineering\, and Mechanical Engineering\, Massachusetts Institute of Technology (MIT)\n\n  \nAbstract: “Mice are not little people” – a refrain becoming louder as the strengths and weaknesses of animal models of human disease become more apparent.  At the same time\, three emerging approaches are headed toward integration:  powerful systems biology analysis of cell-cell and intracellular signaling networks in patient-derived samples; 3D tissue engineered models of human organ systems\, often made from stem cells; and micro-fluidic and meso-fluidic devices that enable living systems to be sustained\, perturbed and analyzed for weeks in culture.  This talk will highlight the integration of these rapidly moving fields to understand difficult clinical problems\, with an emphasis on translating academic discoveries into practical use.  Technical challenges in modeling complex diseases with “organs on chips” approaches include the need for relatively large tissue masses and organ-organ cross talk to capture systemic effects\, as well as new ways of thinking about scaling to capture multiple different functionalities from drug clearance to cytokine signaling crosstalk. Examples in gynecology\, metabolic diseases and other chronic inflammatory conditions will be highlighted.\n  \nHosted by: Dr. Peter Zandstra\, Director – Michael Smith Laboratories and the School of Biomedical Engineering\, UBC\n  \nZoom registration link: https://ubc.zoom.us/meeting/register/u5EtdO6prjoiHdUsc6B540q_n7TUcIqTu4cu\n  \nCo-sponsored by: The Michael Smith Laboratories and the UBC School of Biomedical Engineering
URL:https://scienceinvancouver.com/event/sbme-msl-seminar-dr-linda-griffith-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/04/04-14-2021-MSL-Seminar-Series-Linda-Griffith.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T150000
DTEND;TZID=America/Vancouver:20210414T160000
DTSTAMP:20260407T091556
CREATED:20210401T215554Z
LAST-MODIFIED:20210401T215554Z
UID:31070-1618412400-1618416000@scienceinvancouver.com
SUMMARY:SBME & MSL Seminar: Dr. Linda Griffith
DESCRIPTION:Humanizing Drug Development: From Organoids to Organs-on-Chips\nSpeaker: Dr. Linda Griffith – School of Engineering Professor of Teaching Innovation\, Biological Engineering\, and Mechanical Engineering\, Massachusetts Institute of Technology (MIT)\n\n  \nAbstract: “Mice are not little people” – a refrain becoming louder as the strengths and weaknesses of animal models of human disease become more apparent.  At the same time\, three emerging approaches are headed toward integration:  powerful systems biology analysis of cell-cell and intracellular signaling networks in patient-derived samples; 3D tissue engineered models of human organ systems\, often made from stem cells; and micro-fluidic and meso-fluidic devices that enable living systems to be sustained\, perturbed and analyzed for weeks in culture.  This talk will highlight the integration of these rapidly moving fields to understand difficult clinical problems\, with an emphasis on translating academic discoveries into practical use.  Technical challenges in modeling complex diseases with “organs on chips” approaches include the need for relatively large tissue masses and organ-organ cross talk to capture systemic effects\, as well as new ways of thinking about scaling to capture multiple different functionalities from drug clearance to cytokine signaling crosstalk. Examples in gynecology\, metabolic diseases and other chronic inflammatory conditions will be highlighted.\n  \nHosted by: Dr. Peter Zandstra\, Director – Michael Smith Laboratories and the School of Biomedical Engineering\, UBC\n  \nZoom registration link: https://ubc.zoom.us/meeting/register/u5EtdO6prjoiHdUsc6B540q_n7TUcIqTu4cu\n  \nCo-sponsored by: The Michael Smith Laboratories and the UBC School of Biomedical Engineering
URL:https://scienceinvancouver.com/event/sbme-msl-seminar-dr-linda-griffith-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/04/04-14-2021-MSL-Seminar-Series-Linda-Griffith.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210414T150000
DTEND;TZID=America/Vancouver:20210414T160000
DTSTAMP:20260407T091556
CREATED:20210401T215554Z
LAST-MODIFIED:20210401T215554Z
UID:32530-1618412400-1618416000@scienceinvancouver.com
SUMMARY:SBME & MSL Seminar: Dr. Linda Griffith
DESCRIPTION:Humanizing Drug Development: From Organoids to Organs-on-Chips\nSpeaker: Dr. Linda Griffith – School of Engineering Professor of Teaching Innovation\, Biological Engineering\, and Mechanical Engineering\, Massachusetts Institute of Technology (MIT)\n\n  \nAbstract: “Mice are not little people” – a refrain becoming louder as the strengths and weaknesses of animal models of human disease become more apparent.  At the same time\, three emerging approaches are headed toward integration:  powerful systems biology analysis of cell-cell and intracellular signaling networks in patient-derived samples; 3D tissue engineered models of human organ systems\, often made from stem cells; and micro-fluidic and meso-fluidic devices that enable living systems to be sustained\, perturbed and analyzed for weeks in culture.  This talk will highlight the integration of these rapidly moving fields to understand difficult clinical problems\, with an emphasis on translating academic discoveries into practical use.  Technical challenges in modeling complex diseases with “organs on chips” approaches include the need for relatively large tissue masses and organ-organ cross talk to capture systemic effects\, as well as new ways of thinking about scaling to capture multiple different functionalities from drug clearance to cytokine signaling crosstalk. Examples in gynecology\, metabolic diseases and other chronic inflammatory conditions will be highlighted.\n  \nHosted by: Dr. Peter Zandstra\, Director – Michael Smith Laboratories and the School of Biomedical Engineering\, UBC\n  \nZoom registration link: https://ubc.zoom.us/meeting/register/u5EtdO6prjoiHdUsc6B540q_n7TUcIqTu4cu\n  \nCo-sponsored by: The Michael Smith Laboratories and the UBC School of Biomedical Engineering
URL:https://scienceinvancouver.com/event/sbme-msl-seminar-dr-linda-griffith-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/04/04-14-2021-MSL-Seminar-Series-Linda-Griffith.jpg
END:VEVENT
END:VCALENDAR